Biotech SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 30, 2020
Biotech Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor December 29, 2020
Biotech Hepion Pharmaceuticals Announces Positive Top Line Data for Low Dose CRV431 in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH December 29, 2020
Biotech FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 29, 2020
Biotech FBIO, NAK & SPLK Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm December 29, 2020
Biotech CLSN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Celsion Corporation Shareholders With Losses Exceeding $150K of Class Action and Lead Plaintiff Deadline: December 28, 2020 December 29, 2020
Biotech Ampio Receives feedback from the FDA on Ampio’s Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee December 29, 2020
Search
Biotech
December 30, 2020
December 30, 2020
December 30, 2020
December 29, 2020
December 29, 2020
December 29, 2020
December 29, 2020
December 29, 2020
December 29, 2020
December 29, 2020
